BEHIND GREEN TEA

A study published this week in the journal Nature Nanotechnology find, a molecule that is the main ingredient in green tea can be used as a carrier or carriers of anticancer protein, - forming a stable therapeutic nanocomplexes and effective.

These findings by researchers could help build a better health care system. To come to this conclusion, Eun Joo Chung and colleagues used molecular (-) - epigallocatechin-3-O-gallate (EGCG) - a molecule that is found in green tea, - to create an anticancer protein carrier Herceptin. Excess EGCG compared to other carrier is to have anticancer effects as well. The researchers then injected nanocomplexes EGCG-Herceptin in mice. They then found that certain tumors in mice reduced growth in the longer term.

When designing a drug carrier, several factors must be considered, for example, have to attack the tumor. Then, the ratio of the drug carrier, because the use of high amounts can cause toxicity if the body is not able metabolizes it. In addition, the drug could turn too complex becomes ineffective, if the body against (medicine) and remove it too quickly, such as reported by Medical News Today.